Regulatory News
Monday, June 6, 2016
UPDATE 2-Pfizer's opioid painkiller can be manipulated for abuse - FDA
June 6 (Reuters) - Pfizer Inc's experimental
long-acting opioid painkiller can be manipulated despite its
potential to deter abuse, according to a preliminary review by
the U.S. Food and Drug...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment